Midgard Science

mAbxience

Lugano, Switzerland mabxience.com

From their website, Nov 2026

Work here? Claim this listing

About

mAbxience is a vertically integrated biopharmaceutical company that develops and manufactures biologics, with a focus on biosimilars and innovator biologics. It provides end-to-end B2B development and CDMO services from R&D through commercial supply, with sites in Spain and Argentina.

Services

  • Biopharmaceutical development

    Develops biologics with in-house R&D capabilities, including work specialized in biosimilars and innovator biologics.

  • CDMO services

    Provides integrated development and manufacturing services tailored to client requirements, from research batches to commercial batches.

  • Cell line development and banking

    Supports early-stage programs with cell line development and banking activities.

    Cell line development

  • Analytical development

    Develops analytical methods and capabilities to support development, validation, and manufacturing.

  • Process development

    Develops robust and scalable processes for biopharmaceutical programs.

  • Formulation development

    Develops formulations to support clinical and commercial supply.

  • Demo runs

    Performs demo runs as part of early-stage development programs.

  • Clinical manufacturing

    Produces clinical batches under GMP conditions.

    CDMO: development & manufacturing

  • Tech transfer and manufacturing readiness

    Supports technology transfer and readiness for manufacturing scale-up and transfer.

  • Process validation and analytical validation

    Carries out validation work to support regulatory and manufacturing requirements.

  • cGMP manufacturing and commercial supply

    Manufactures biologics for commercial supply and market needs.

    CDMO: development & manufacturing

  • Quality and regulatory support

    Provides quality and regulatory support across development and manufacturing activities.

Turnaround
IND ready in 12 months · Manufacturing-ready in 18 months

Capabilities

Assays and studies
Antibodies · Bioreactors · Analytical development · Process development · Analytical validation · Process validation
Scale and capacity
3L-200L small scale GMP production · 200L clinical batches · 2L to 4,000L bioreactors · 6,000L bioreactors coming soon · 12,000L batches coming soon · Combined capacity of 50,000L · From 50,000L to 74,000L total capacity · 3 production sites · 5 production lines + 1 coming soon

Instruments and platforms

  • Single-use bioreactors

Modalities and species

Modalities
Antibody · Bispecific · ADC · Cell therapy · Vaccine · Biosimilar

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: production plants and small-scale GMP production

Company

Type
CRDMO
Founded
2019

Locations

Address
biomanufacturing 2014 – 2015 Genhelix: mAbxience Spain R&D center First launch of
Sites
Spain, Spain · Argentina, Argentina · Madrid, Spain · Genhelix, Spain · Garín, Argentina · Munro, Argentina
Serves
worldwide, Europe, South America

Public records

Parent company
MABXIENCE RESEARCH SL · DE GLEIF
FDA drug establishment registration
3017999629 · ANALYSIS; API MANUFACTURE source

Similar labs

Work here? Claim this listing